A systematic approach for early identification of BP effects during development of new drugs.
Daniel B. Goodman, MD
Advertisement
Articles by Daniel B. Goodman, MD
More attention is being paid to blood pressure effects in new chemical entities under development for non-hypertension indications.
Advertisement
Latest Updated Articles
A Proposed Approach for Blood Pressure Evaluation During Early Phase Human Trials of New DrugsPublished: July 22nd 2014 | Updated:
- Blood Pressure Evaluation During Early Phase Trials
Published: October 1st 2014 | Updated:
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Life Sciences Can’t Afford Fragmented Data and Disconnected Teams
2
ACT Brief: Building a Digital Thread in Life Sciences, CRO Sourcing Decisions and Site Burden, and Lilly’s Oral GLP-1 Phase III Results
3
Applying AI to Automate Workflows Without Disrupting Sites
4
FDA Approves Subcutaneous Lunsumio VELO Based on GO29781 Trial Results in Relapsed or Refractory Follicular Lymphoma
5